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A B S T R A C T
Radial immunodiffusion technique was used to estimate salivary immunoglobulin A,
and enzyme-linked immunosorbent assay for estimation of serum IgA, IgG and IgM in
30 patients with acute recurrent aphthous ulceration (RAU) and during remission period
compared to 30 healthy controls. Significantly elevated level of salivary IgA (p < 0.05)
was found in patients with minor RAU when compared to the control group. Serum IgA
level was elevated in patients with minor acute RAU when compared to the controls
(p < 0.05). Serum immunoglobulin level of IgG and IgM showed no differences between
patients with either minor or major recurrent aphthous ulceration and controls.
Introduction
Recurrent aphthous ulceration (RAU)
is a common oral disease appearing usu-
ally on nonkeratinized oral mucosa, espe-
cially on the tongue, vestibulum, palate
and buccal mucosa1. The etiology of the
disease is still not completely understood.
Many local and systemic factors have
been associated with these conditions as
well as evidence of a genetic and immu-
nopathogenic basis for RAU2,3. Evidence
suggests that RAU is connected with chro-
nic bowel disease, haematinic deficien-
cies, AIDS, food hypersensitivity, radia-
tion and severe stress4,5. Some authors6
suggested the possible viral etiology in
the development of RAU. The common
prevalence is 20% and up to 55% depend-
ing on population sampling and criteria
used for inclusion in this symptom com-
plex7,8. The most common presentation
are minor recurrent aphthous ulcers:
round, painful ulcers up to 10 mm in di-
ameter that heal within 10–14 days with-
out scarring. Major ulcers are larger than
10 mm in diameter, and can last for sev-
eral weeks and frequently scar. Numer-
ous authors have investigated cellular
and humoral immune response of pa-
tients with RAU9–11. A study by Sistig et
al.12 showed alterations in cellular immu-
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nity especially in phagocytosis, ADCC,
and NK cells activity. Various authors
have reported that patients with RAU
show changes in the serum immunoglob-
ulin levels13,14.
The aim of our study was to examine
the involvement of humoral immunity in
the development of RAU and to deter-
mine the role of salivary IgA in the pro-
cess of healing in patients with RAU.
Material and Methods
The study population consisted of 30
patients (16 men and 14 women), 22 with
minor ulcers and 8 with major ulcers (age
range 17–79 yrs, mean age 40 yrs) with
clinical features, history and verified di-
agnosis of RAU. Informed consent accord-
ing to Helsinki II was obtained from each
participant. Criteria for differentiation of
the aphthae were diameter of the lesion,
according to Lehner15. Those less than 10
mm in diameter were considered as mi-
nor, while those bigger than 10 mm as
major. We analyzed patients with acute
RAU (ulcers 2 days old) as well as during
remission period (1 week after healing).
None of the patients were smokers, nor
had received previous treatment for RAU.
Thirty healthy volunteers (18 men and 12
women) with no history of RAU served as
controls, they all had healthy oral mucosa
(age range 20–58 yrs, mean age 39 yrs).
Peripheral blood samples (5ml) were ta-
ken by venepuncture from patients and
controls, between 8–12 a.m. into plastic
tubes. Serum was centrifuged and ali-
quots were stored at –20 °C until ready to
be used. Participants were asked to sus-
tain from eating and drinking for two
hours prior to saliva collection. The un-
stimulated whole saliva was collected be-
tween 10–12 a.m. according to Wu-Wang
et al.16. All participants were instructed
to collect saliva in their mouths for 5 min
without swallowing and to spit into a
clean plastic container. Salivary flow rate
was recorded. The pooled samples were
immediately placed in a –20° freezer un-
til ready for analysis.
The level of IgA in saliva was deter-
mined by radial immunodiffusion tech-
nique according to Mancini at al.17 using
specific anti-human 11S IgA serum (In-
stitute of Immunology, Zagreb, Croatia).
During the determination the samples of
saliva were diluted three times. In deter-
mined places, standards of 11S IgA and
diluted samples were applied. The pro-
cess of immunodiffusion was continued
for 48 hours at room temperature. In or-
der to remove unbound proteins the pla-
tes were washed 48 hours in 3% (w/v) so-
dium chloride with several changes of
washing solution. The excess amount of
sodium chloride was removed by washing
the plates with distilled water during the
next 24 hours. To ensure visibility of the
bands obtained by immunoprecipitation,
the plates were placed for 45 minutes in
1% (w/v) solution of tannic acid and then
washed with distilled water. The diame-
ter of the precipitating ring was mea-
sured by radial immunodiffusion reader.
The concentration of tested samples was
estimated by using standard calibration
curve, and expressed in mg/ml.
Serum IgA, IgG and IgM were deter-
mined using commercially available dou-
ble sandwich ELISA technique (North-
east Biomedical Laboratories, Uxbridge,
Middlesex).
Statistical analysis was performed us-
ing ANOVA test, and values lower than
0.05 were considered as significant.
Results
Serum IgA values were significantly
different between patients with acute mi-
nor RAU and controls (p < 0.05; F=1.23)
(Table 1). Serum IgA values in patients
with major RAU were not significantly
different in acute RAU, during remission
compared to controls. Serum IgG and
IgM values did not differ significantly be-
tween patients with minor and major
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acute RAU, during remission period, and
controls. Salivary IgA values differed sig-
nificantly during the acute stage of recur-
rent aphthous ulcers in patients with mi-
nor RAU, when compared to controls
(p < 0.05; F=6.85). The values of salivary
IgA were significantly higher in the acute
stage of the disease than in controls. In
major RAU there was no difference in sal-
ivary IgA between acute stage, remission
and healthy controls (Table 1).
Salivary flow rates did not differ sig-
nificantly between patients with acute
RAU (either minor or major), during re-
mission period and controls (Table 2).
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TABLE 1
SERUM IMMUNOGLOBULINS A, G, M AND SALIVARY IMMUNOGLOBULIN A LEVELS IN ACUTE
PHASE AND DURING REMISSION PERIOD IN PATIENTS WITH MINOR AND MAJOR RECURRENT








IgA (mg/mL) 3.143  0.721 2.732  0.833 2.764  2.482
IgG (mg/mL) 11.936  2.856 12.956  2.513 12.059  3.259
IgM (mg/mL) 1.248  0.717 1.439  0.772 1.258  0.422
sIgA (mg/mL) 0.079  0.026 0.065  0.002 0.054  0.024
MAJOR RAU
IgA (mg/mL) 2.728  1.162 2.534  1.183 2.764  2.482
IgG (mg/mL) 11.977  2.743 13.217  2.605 12.059  3.259
IgM (mg/mL) 1.138  0.510 1.341  0.548 1.258  0.422
sIgA (mg/mL) 0.068  0.021 0.055  0.024 0.054  0.024
Porter et al. Number of patients
with RAU
IgA (mg/mL)  (1)
IgG (mg/mL)  (1)
IgM (mg/mL)  (5)
IgM, IgG (mg/ml)  (1)
TABLE 2
COMPARISON OF SALIVARY FLOW RATES IN PATIENTS WITH MINOR AND MAJOR RAU
DURING ACUTE PHASE AND REMISSION PERIOD AND IN CONTROLS, AS WELL AS IN
STUDY OF WU-WANG ET AL.16
Major RAU (ml/min) Minor RAU (ml/min) Controls (ml/min)
Acute 0.54  0.07 Acute 0.55  0.05 0.59  0.06
Remission 0.56  0.05 Remission 0.57  0.08
Wu-Wang et al.
Acute 0.55  0.04 0.58  0.07
Remission 0.52  0.07
Discussion
Salivary immunoglobulin A in pati-
ents with recurrent aphthous ulceration
has not yet been investigated comprehen-
sively. Many studies18–20 have been per-
formed with the aim of investigating the
physiology of salivary IgA and its connec-
tion with diseases of the oral mucosa such
as recurrent aphthous ulcerations.
The results of our study show that se-
rum IgA levels are only elevated in minor
acute RAU when compared with controls.
In patients with major acute RAU, and
during remission period, levels of serum
IgA remained within the physiologic
range. Serum IgG and IgM levels did not
differ between patients with minor and
major RAU either during acute phase or
remission period, when compared to the
control group. We found significantly
higher salivary IgA level in patients with
minor acute recurrent oral ulceration
when compared to controls and also in
comparison to the values of IgA in major
acute RAU. Salivary IgA levels during
the remission period both in patients
with minor and major RAU, were normal.
Natah21 found that elevated levels of se-
rum IgA and IgG were present in patients
with recurrent aphthous ulcerations, and
that salivary IgA did not differ in patients
with RAU compared to the control group.
Güven22 also found elevated levels of se-
rum IgA and IgM in patients with RAU.
However the author did not find any
changes in serum IgG levels. Porter et
al.13 described IgG subclass levels in the
serum of patients with minor oral aph-
thous stomatitis, and concluded that the-
re is no evidence to suggest that changes
in IgG subclass are present in patients
with RAU. In that study patients did not
have active lesions of the oral mucosa. A
more recent study by Vincente et al.14
suggested that low serum levels of IgG2
in patients with acute ulcers might play
an important role in the pathogenesis of
RAU. The same authors also reported
that serum IgG subclass level as well as
total IgA may undergo changes which are
dependant on different periods of activity
and quiescence of the disease. Ben-Aryeh
et al.23 found that salivary IgA and serum
IgA and IgG in patients with either dor-
mant or acute RAU were within the physio-
logic range for healthy people. Authors24
found lowered serum IgA in patients with
acute RAU. Bennet and Reade25 found
that salivary IgA in patients with minor
aphthous ulceration undependable of stage
disease showed no deviation from the
control group. Both in patients with mi-
nor and major RAU, during acute phase,
remission and in controls salivary flow
rate was within normal ranges and we
can conclude that the quantity of saliva is
unchanged in patients with RAU.
We can conclude that the local immu-
nological defense response of saliva is ac-
tivated in patients with minor RAU. Dif-
ferent values of serum immunoglobulin
levels described by various authors could
be due to the different disease stages of
RAU investigated, as well as to the differ-
ent technical methods employed. Further
studies are needed in order to explain the
etiopathologic mechanism in the develop-
ment of RAU.
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SERUMSKI IMUNOGLOBULINI A, G, M, TE SALIVARNI
IMUNOGLOBULIN A U REKURENTINM AFTOZNIM ULCERACIJAMA
S A @ E T A K
Za odre|ivanje imunoglobulina A u slini kori{tena je tehnika radijalne imunodi-
fuzije, a za odre|ivanje serumskog IgA, IgG i IgM kori{ten je enzimski imunotest.
Ispitivanje je izvr{eno kod 30 bolesnika s rekurentnim aftoznim ulceracijama (RAU) u
akutnoj fazi i tijekom perioda remisije te uspore|eno s nalazom 30 zdravih ispitanika.
Zna~ajno povi{ena razina IgA u slini (p < 0.05) prona|ena je u bolesnika s minornim
RAU u usporedbi s kontrolnom skupinom. Razina serumskog IgA povi{ena je u bole-
snika s akutnim minornim RAU u usporedbi s kontrolnom skupinom. Razine serum-
skog imunoglobulina IgG i IgM nisu pokazale razlike izme|u bolesnika s rekurentnim
aftoznim ulceracijama bilo minor ili major i kontrolne skupine.
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